Show simple item record

dc.contributor.authorLópez-Muñoz, F.
dc.contributor.authorRubio, G.
dc.contributor.authorMolina Martín, Juan de Dios
dc.contributor.authorShen, Winston W.
dc.contributor.authorPerez Nieto, Miguel Ángel
dc.contributor.authorMoreno, Raquel
dc.contributor.authorHuelves, Lorena
dc.contributor.authorNoriega, Concha
dc.contributor.authorGarcía-García, P.
dc.contributor.authorÁlamo González, C
dc.date.accessioned2018-06-25T16:06:02Z
dc.date.available2018-06-25T16:06:02Z
dc.date.issued2013
dc.identifier.issn1139-9287
dc.identifier.urihttp://hdl.handle.net/20.500.12020/755
dc.description.abstractObjectives: We carried out a bibliometric study on the scientific publications in relation to atypical antipsychotic drugs (AADs) in Spain. Methods: We used the EMBASE and MEDLINE databases and we applied some bibliometric indicators of paper production and dispersion (Price’s law and Bradford’s law, respectively). We also calculated the participation index of the different countries and correlated the bibliometric data with some social and health data (total per capita expenditure on health and gross domestic expenditure on research and development). Results: We collected 656 original papers published between 1988 and 2011. Our study results fulfilled Price’s law with scientific production on AADs showing exponential growth (correlation coefficient r = 0.9693, vs. r = 0.9177 after linear adjustment). The most widely studied drugs were risperidone (181 papers), olanzapine (143), clozapine (94), and quetiapine (74). Division into Bradford zones yielded a nucleus occupied by the European Psychiatry and European Neuropsychopharmacology (70 articles). Totally 194 different journals were published, with 5 of the first 10 used journals having an impact factor being greater than 4. Conclusion: The publications on AADs in Spain have undergone exponential growth over the studied period, without evidence of reaching a saturation point.es
dc.language.isoeses
dc.language.isoenes
dc.publisherActas Españolas de Psiquiatríaes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleMapping the scientific research on atypical antipsychotic drugs in Spain: a bibliometric assessmentes
dc.title.alternativeLa investigación sobre fármacos antipsicóticos atípicos en España: una evaluación bibliométricaes
dc.typearticlees
dc.issue.number6es
dc.journal.titleActas Españolas de Psiquiatríaes
dc.page.initial349es
dc.page.final360es
dc.rights.accessRightsopenAccesses
dc.subject.areaPsicologíaes
dc.subject.keywordAtypical antipsychoticses
dc.subject.keywordBibliometryes
dc.subject.keywordBipolar disorderes
dc.subject.keywordSchizophreniaes
dc.subject.keywordSpaines
dc.subject.unesco3201.05 Psicología Clínicaes
dc.volume.number41es


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional